Opioid Sedation Scale
The Pasero Opioid-Induced Sedation Scale (POSS) is the validated scale recommended for assessing opioid-induced sedation, with a critical threshold at score ≥2 indicating early opioid-induced ventilatory impairment requiring immediate intervention. 1
The POSS Scale Structure
The POSS uses a 5-point assessment system:
- S = Sleep, easily aroused
- 1 = Awake and alert
- 2 = Occasionally drowsy, easy to rouse
- 3 = Frequently drowsy, arousable, drifts off during conversation
- 4 = Somnolent, minimal or no response to stimulation
Critical Score Interpretation
A POSS score of 2 or higher signals early opioid-induced ventilatory impairment and mandates action. The goal is to titrate opioids to maintain sedation scores consistently below 2. 1 This threshold exists because sedation precedes respiratory depression and represents the most reliable clinical marker for detecting impending respiratory compromise before significant patient harm occurs. 1
Why POSS Over Other Scales
International guidelines explicitly recommend against using sedation scales that include an "S" (sleeping) category as the primary assessment point. 1 The critical flaw: patients may wake easily when disturbed but then either stay awake or struggle to remain awake. If they cannot stay awake, this represents dangerous opioid-induced sedation that could be missed if the assessor simply notes "sleeps but easily aroused" and moves on without determining whether the patient can maintain wakefulness. 1
The POSS outperforms alternatives in clinical validation studies, demonstrating superior reliability, validity, and—crucially—the highest percentage agreement with correct nursing actions among tested sedation scales. 2 Nurses consistently rate it higher for ease of use, confidence in assessment, and usefulness for clinical decision-making. 2
Clinical Implementation Algorithm
Monitoring Requirements
All patients receiving opioids for acute pain must have sedation assessed at appropriate, repeated intervals. 1 The frequency should increase with:
- Higher opioid doses
- Concurrent sedating medications (benzodiazepines, gabapentinoids)
- Advanced age (older patients develop both analgesia and ventilatory impairment at lower doses) 1
Action Thresholds
POSS Score 0-1: Continue current regimen with routine monitoring
POSS Score ≥2: Immediate intervention required:
- Hold opioid administration
- Increase monitoring frequency
- Consider naloxone if respiratory rate declining or oxygen saturation dropping
- Reassess pain management strategy—escalating sedation with persistent pain suggests non-opioid-responsive pain requiring alternative approaches 1
POSS Score 3-4: Medical emergency—prepare for respiratory support and naloxone administration 1
Evidence Quality and Validation
The POSS has been validated across multiple clinical settings including postanesthesia care units 3, pediatric populations 4, and general medical-surgical units 2. Implementation studies consistently show increased documentation clarity, improved nurse-to-nurse communication during handoffs, and enhanced detection of unintended sedation. 3, 5
A multisite retrospective study found that POSS implementation increased detection of opioid-induced unintended sedation (12.2% vs 3.8%, p=0.04), suggesting the scale identifies at-risk patients before they progress to requiring naloxone. 5 The scale has been cross-culturally adapted for international use, further supporting its validity. 6
Common Pitfalls to Avoid
Do not rely on pain scores alone to guide opioid titration—this increases ventilatory impairment risk. 1 Focus instead on patient function alongside sedation assessment.
Do not assume normal oxygen saturation means safe sedation. Studies show oxygen saturation remains comparable between moderate and deep sedation states. 7 Sedation assessment via POSS is more sensitive than vital signs for detecting early opioid-induced ventilatory impairment.
Do not use continuous opioid infusions when avoidable—they increase risk and prevent rapid dose adjustment. 1
Avoid concurrent sedating medications (benzodiazepines, gabapentinoids, alcohol) which synergistically increase ventilatory impairment risk. 1